These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24447788)

  • 1. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
    Kumar S; Xu X; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and dissolution performance of spray-dried naproxen nano-crystals.
    Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugars as bulking agents to prevent nano-crystal aggregation during spray or freeze-drying.
    Kumar S; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Aug; 471(1-2):303-11. PubMed ID: 24939612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    J Pharm Sci; 2015 Sep; 104(9):3018-28. PubMed ID: 25195539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality by Design approach to spray drying processing of crystalline nanosuspensions.
    Kumar S; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):234-42. PubMed ID: 24412337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Pharm Res; 2015 May; 32(5):1694-703. PubMed ID: 25385690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation design and evaluation of amorphous ABT-102 nanoparticles.
    Jog R; Kumar S; Shen J; Jugade N; Tan DC; Gokhale R; Burgess DJ
    Int J Pharm; 2016 Feb; 498(1-2):153-69. PubMed ID: 26705150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions.
    Figueroa CE; Bose S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1046-55. PubMed ID: 23916460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of spray granulation for conversion of a nanosuspension into a dry powder form.
    Bose S; Schenck D; Ghosh I; Hollywood A; Maulit E; Ruegger C
    Eur J Pharm Sci; 2012 Aug; 47(1):35-43. PubMed ID: 22565066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.
    Meruva S; Thool P; Shah S; Karki S; Bowen W; Ghosh I; Kumar S
    Int J Pharm; 2019 Sep; 568():118189. PubMed ID: 30851385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
    Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
    Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
    Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van den Mooter G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):127-35. PubMed ID: 18644441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY; Shah DA; Dave RH
    Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and solidification of redispersible nanosuspensions.
    Zhang X; Guan J; Ni R; Li LC; Mao S
    J Pharm Sci; 2014 Jul; 103(7):2166-2176. PubMed ID: 24840928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development.
    Czyz S; Wewers M; Finke JH; Kwade A; van Eerdenbrugh B; Juhnke M; Bunjes H
    Eur J Pharm Biopharm; 2020 Jul; 152():63-71. PubMed ID: 32376369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.